Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1
Status:
TERMINATED
Trial end date:
2023-12-22
Target enrollment:
Participant gender:
Summary
The investigators will study the effect of microdoses of glucagon at the site of subcutaneous insulin injection. The investigators have unpublished data from anesthetized pigs indicating a major enhancement of insulin absorption.